210 filings
8-K
BCLI
Brainstorm Cell Therapeutics, Inc.
16 Apr 24
BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn
9:31pm
8-K
BCLI
Brainstorm Cell Therapeutics, Inc.
11 Apr 24
Other Events
6:10am
8-K
BCLI
Brainstorm Cell Therapeutics, Inc.
9 Apr 24
BrainStorm Cell Therapeutics Announces Agreement with FDA on a
6:05am
8-K
BCLI
Brainstorm Cell Therapeutics, Inc.
2 Apr 24
Entry into a Material Definitive Agreement
4:15pm
8-K
BCLI
Brainstorm Cell Therapeutics, Inc.
1 Apr 24
BrainStorm Cell Therapeutics Announces Full Year 2023 Financial Results and Provides Corporate Update
8:15am
8-K
hftfslid 6zq7dz6h
20 Dec 23
BrainStorm Issues 2023 Letter to Shareholders
5:04pm
8-K
5wttez 7qdaznxe
22 Nov 23
BrainStorm Cell Therapeutics Announces In-Person Meeting with the FDA to Discuss Confirmatory Phase 3 Trial for NurOwn® in ALS
6:03am
8-K
1n4ilq6j7r8a7bcvc0
14 Nov 23
BrainStorm Cell Therapeutics Announces Third quarter 2023 Financial Results and Provides Corporate Update
12:00am
8-K
cbfugant9wz5lo
9 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:01pm
8-K
1lsbfvzmia da4d
3 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:07pm
8-K
mmc24awx60m6 z4q
24 Oct 23
BrainStorm Cell Therapeutics Announces Strategic Realignment
7:30am
8-K
9xhu9hcga3ml65a 8tm8
14 Aug 23
BrainStorm Cell Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update
7:21am
8-K
wjr1m01oo4
19 Jul 23
Brainstorm Cell Therapeutics Announces Pricing of $7.5 Million Registered Direct Offering
4:05pm
8-K
1intlb
20 Jun 23
BrainStorm Cell Therapeutics Appoints Nir Naor as Board Member and Audit Committee Chair
5:01pm
8-K
tcimxr 0by
6 Jun 23
Regulation FD Disclosure
8:58am
8-K
2recxnmnl2x15jxqq3ty
24 May 23
Departure of Directors or Certain Officers
5:01pm
8-K
9m0cqj3n ip
15 May 23
BrainStorm Cell Therapeutics Announces First Quarter 2023 Financial Results and Provides Corporate Update
7:15am
8-K
gp9ux25l4x6kz78r2e
30 Mar 23
BrainStorm Cell Therapeutics Announces Full Year 2022 Financial Results and Provides a Corporate Update
7:18am
8-K
vcw6i2v
27 Mar 23
Regulation FD Disclosure
6:20am
8-K
ng4xzxk
11 Jan 23
Submission of Matters to a Vote of Security Holders
4:05pm